Antiviral Pathway Activation in Patients with Chronic Fatigue Syndrome and Acute Infection
Open Access
- 15 December 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (12) , 2080-2081
- https://doi.org/10.1086/324357
Abstract
Gene expression of key enzymes in 2 antiviral pathways (ribonuclease latent [RNase L] and RNA-regulated protein kinase [PKR]) was compared in 22 patients with chronic fatigue syndrome (CFS), 10 patients with acute gastroenteritis, and 21 healthy volunteers. Pathway activation in the group of patients with infections differed significantly from that of the other 2 groups, in whom there was no evidence of upregulation. Therefore, assay of activation is unlikely to provide the basis for a diagnostic test for CFS.Keywords
This publication has 3 references indexed in Scilit:
- A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndromeThe American Journal of Medicine, 2000
- Frustrating survey of chronic fatigueThe Lancet, 1996
- The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and StudyAnnals of Internal Medicine, 1994